How Healthy is Your Pharmacy?

By William Popomaronis, R.Ph.

Financial Measures for the DMEPOS Competitive Bidding Released by CMS

CMS has released the measures that will be used to evaluate the financial stability of suppliers that bid under the new Medicare DMEPOS Competitive Bidding Program. All bids must include certain financial documentation in order for the supplier to be considered for a contract under the program. CMS and its Competitive Bidding Implementation Contractor (CBIC) will evaluate each bidder's financial documentation to determine whether the supplier will be able to participate in the program and maintain viability for the duration of the contract period.

The financial measures are standard accounting ratios commonly used to evaluate financial health. The following financial ratios will be used:

  • Current ratio = current assets/current liabilities
  • Collection period = (accounts receivable/sales) x 360
  • Accounts payable to sales = accounts payable/net sales
  • Quick ratio = (cash + accounts receivable)/current liabilities
  • Current liabilities to net worth = current liabilities/net worth
  • Return on sales = net sales/inventory
  • Sales to Inventory
  • Working capital = current assets - current liabilities
  • Quality of earnings = cash flow from operations/(net income + depreciation)
  • Operating cash flow to sales = cash flow from operations/(revenue - adjustment to revenue)

CMS and the CBIC will calculate each bidder's financial ratios using the financial information submitted as part of the bid. CMS and the CBIC will also be utilizing the supplier's credit history in evaluating the financial health of the supplier.

 
 
 

William Popomaronis, R.Ph., is vice president, long term and home health care services for the National Community Pharmacists Association (NCPA). He is also the only pharmacist member of Medicare’s Program Advisory and Oversight Committee (PAOC), which provides advice on the development and implementation of the DME Competitive Acquisition Program.

 
 
  Bayer HealthCare, Diabetes Care, has underwritten the costs of this communication. The information expressed in this communication are the views of NCPA. Bayer is not responsible for the accuracy of the information expressed in this communication. Any questions related to DME Accreditation and/or Competitive Bidding for DMEPOS should be directed to the Centers for Medicare and Medicaid Services or NCPA.